Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | METAP2 | P50579 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | PPP1CA | P62136 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21736235 | 0.94 | AHR (0.33) | NPSR1METAP2AHR | |
| SCHEMBL20670060 | 0.88 | SMN1; SMN2 (0.38) | NPSR1L3MBTL1RAB9AKDM4EATM | |
| SCHEMBL21736293 | 0.85 | SMN1; SMN2 (0.38) | NPSR1L3MBTL1RAB9AKDM4EATM | |
| SCHEMBL21736051 | 0.84 | TSHR (0.35) | METAP2L3MBTL1RAB9AMAPTPPP1CA | |
| SCHEMBL20669988 | 0.84 | HCRTR1 (0.33) | NPSR1L3MBTL1MAPTKDM4EAHR | |
| SCHEMBL18273484 | 0.83 | SMN1; SMN2 (0.41) | NPSR1L3MBTL1RAB9AKDM4EATM | |
| SCHEMBL21736055 | 0.81 | SMN1; SMN2 (0.34) | NPSR1L3MBTL1RAB9ANPY5RKDM4E | |
| SCHEMBL21735901 | 0.80 | CHEK2 (0.31) | L3MBTL1SMN1; SMN2 | |
| SCHEMBL16905839 | 0.80 | SMN1; SMN2 (0.41) | NPSR1L3MBTL1RAB9AKDM4EATM | |
| SCHEMBL20670175 | 0.79 | NPY5R (0.34) | METAP2L3MBTL1RAB9AMAPTPPP1CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11530225-B2 | Compound and organic light-emitting diode comprising same | LG CHEM, LTD. (KR) | 2022-12-20 | — | — | US | disclosed |
| US-20200055865-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2020-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11530225-B2 | Compound and organic light-emitting diode comprising same | CRY1, CRY2, TRPA1 | NPSR1 4543/4885METAP2 4120/4885L3MBTL1 433/4885 |
| US-20200055865-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | CRY1, CRY2, TRPA1 | NPSR1 4543/4885METAP2 4120/4885L3MBTL1 433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.